Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSunrise Resources PLC Regulatory News (SRES)

Share Price Information for Sunrise Resources PLC (SRES)

Share Price is delayed by 15 minutes
Get Live Data
0.016    0.00 (0.00%)
Bid:
0.015
Ask:
0.017
Spread: 0.002 (13.333%)
Market Cap: £1.50m
SRES Live PriceLast checked at - London Stock Exchange

Intraday Sunrise Resources PLC Share Chart

Holding(s) in Company

14 Jun 2016 11:34

RNS Number : 1458B
Sunrise Resources Plc
14 June 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Sunrise Resources plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Issue of 250,000,000 new ordinary shares by Sunrise Resources plc

ü

3. Full name of person(s) subject to thenotification obligation: iii

Tertiary Minerals plc

4. Full name of shareholder(s)  (if different from 3.):iv

As above

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

10 June 2016

6. Date on which issuer notified:

14 June 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

11%, 10%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B075Z681

102,234,999

102,234,999

102,234,999

102,234,999

N/A

9.16%

N/A

Ordinary Shares

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

102,234,999

9.16%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

N/A

14. Contact name:

Judith Hayes

15. Contact telephone number:

01625 838679

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGGUPWQUPQGUC
Date   Source Headline
28th Feb 20251:29 pmRNSTotal Voting Rights
17th Feb 20255:16 pmRNSIssue of Shares following Conversion & TVR
14th Feb 202511:00 amRNSANNUAL REPORT & NOTICE OF 2025 AGM
13th Feb 20251:27 pmRNS-RUPDATED WEBSITE, PRESENTATION & CEO INTERVIEW
13th Feb 20259:46 amRNSUpdate - Pioche Sepiolite Project
13th Feb 20259:08 amRNSFinal Results
27th Dec 20243:58 pmRNSPioche Sepiolite Project – Tolsa Option
16th Dec 20249:29 amRNSCS PROJECT BULK SAMPLE – CUSTOMER TRIALS
5th Dec 20247:00 amRNSUPDATE ON THE COMPANY’S NATURAL POZZOLAN PROJECTS
2nd Dec 202410:12 amRNSTotal Voting Rights
27th Nov 20247:00 amRNSSALE OF CROW SPRINGS DIATOMITE CLAIMS
13th Nov 20244:28 pmRNSIssue and Allotment of Shares following Conversion
26th Sep 20247:00 amRNSReese Ridge Zinc-Lead-Silver (-Gallium) Project
2nd Sep 20249:17 amRNSTotal Voting Rights
19th Aug 20243:54 pmRNSIssue of Equity and Total Voting Rights
13th Aug 20247:00 amRNSExploration Update – Pioche Sepiolite Project
1st Aug 20247:00 amRNSTotal Voting Rights
15th Jul 202412:27 pmRNSHolding(s) in Company
12th Jul 20245:33 pmRNSHolding(s) in Company
12th Jul 202411:00 amRNSDrill Start – Pioche Sepiolite Project
1st Jul 20249:24 amRNSPlacing & Subscription to Raise £201,500 & TVR
3rd Jun 20247:00 amRNSTotal Voting Rights
30th May 202411:14 amRNSHalf-year Report
29th May 20247:00 amRNSPioche Sepiolite Project, Nevada, USA
24th May 20243:00 pmRNSIssue of Ordinary Shares following Conversion
24th May 20247:00 amRNSCrow Springs Diatomite Project Update
16th May 20249:54 amRNSGarfield Royalty Interest
2nd Apr 20247:00 amRNSSALE OF DIATOMITE CLAIMS
28th Mar 20247:00 amRNSTotal Voting Rights
7th Mar 202411:20 amRNSDIRECTOR DEALING
5th Mar 20247:00 amRNSIssue of Shares following Conversion & TVR
29th Feb 202410:11 amRNSTotal Voting Rights
23rd Feb 202412:27 pmRNSDIRECTOR DEALING, ISSUE OF EQUITY & TVR
23rd Feb 202411:35 amRNSVoting at AGM
22nd Feb 202412:32 pmRNSResult of AGM
26th Jan 202410:00 amRNSANNUAL REPORT AND NOTICE OF 2024 AGM
24th Jan 20247:00 amRNSFinal Results
18th Jan 20247:00 amRNSPioche Sepiolite Project
27th Dec 202310:31 amRNSPioche Sepiolite Project
4th Dec 20231:55 pmRNSGarfield Royalty Interest
1st Dec 20237:00 amRNSInvestor Presentation
22nd Nov 20239:51 amRNSResult of Meeting
7th Nov 20237:00 amRNSProposed Sub-Division of Share Capital
31st Oct 20237:00 amRNSReese Ridge Zinc-Lead-Silver (-Gallium) Project
27th Sep 20237:00 amRNSPioche Project Update
15th Sep 20237:00 amRNSMarket Study and Pozzolan Project Update
31st Aug 20236:09 pmRNSTotal Voting Rights
11th Aug 202312:51 pmRNSIssue of Shares following Conversion & TVR
11th Aug 202312:45 pmRNSISSUE OF WARRANTS
3rd Aug 20234:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.